martes, 29 de diciembre de 2009


December 29, 2009 — The American Diabetes Association (ADA) revised clinical practice recommendations for diabetes diagnosis promote hemoglobin A1c (A1c) as a faster, easier diagnostic test that could help reduce the number of undiagnosed patients and better identify patients with prediabetes. The new recommendations are published December 29 in the January supplement of Diabetes Care.

December 22, 2009 — Intravitreal use of the corticosteroid triamcinolone may slow the progression of diabetic retinopathy, but adverse effects including cataract formation and glaucoma may prevent use of this treatment merely to reduce progression of proliferative diabetic retinopathy (PDR), according to the results of a study reported in the December issue of the Archives of Ophthalmology.

New treatments may change how physicians prevent and treat diabetic retinopathy. The current review describes the pathophysiology of diabetic retinopathy and the best current and emerging practice for its treatment.

No hay comentarios:

Publicar un comentario